MCI-AD, EARLY STAGE ALZHEIMER'S DISEASE

Clinical trials for MCI-AD, EARLY STAGE ALZHEIMER'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new MCI-AD, EARLY STAGE ALZHEIMER'S DISEASE trials appear

Sign up with your email to follow new studies for MCI-AD, EARLY STAGE ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Zapping the brain with VR: a new hope to slow Alzheimer's?

Disease control Not yet recruiting

This study is testing a new, non-drug device for people in the early stages of Alzheimer's disease. The device combines gentle electrical brain stimulation with a multi-sensory virtual reality experience. Researchers want to see if this combination can improve memory, thinking sk…

Matched conditions: MCI-AD, EARLY STAGE ALZHEIMER'S DISEASE

Phase: NA • Sponsor: Yuan Shen • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

MCI-AD, EARLY STAGE ALZHEIMER&#39;S DISEASE

Get alerted when new MCI-AD, EARLY STAGE ALZHEIMER&#39;S DISEASE trials appear

Zapping the brain with VR: a new hope to slow Alzheimer's?

MCI-AD, EARLY STAGE ALZHEIMER'S DISEASE

Get alerted when new MCI-AD, EARLY STAGE ALZHEIMER'S DISEASE trials appear